ImmuCell Corporation

NasdaqCM:ICCC Stock Report

Market Cap: US$39.0m

ImmuCell Management

Management criteria checks 4/4

ImmuCell's CEO is Michael Brigham, appointed in Oct 1991, has a tenure of 32.5 years. total yearly compensation is $395.24K, comprised of 89.9% salary and 10.1% bonuses, including company stock and options. directly owns 2.78% of the company’s shares, worth $1.09M. The average tenure of the management team and the board of directors is 9.2 years and 6.3 years respectively.

Key information

Michael Brigham

Chief executive officer

US$395.2k

Total compensation

CEO salary percentage89.9%
CEO tenure32.5yrs
CEO ownership2.8%
Management average tenure9.2yrs
Board average tenure6.3yrs

Recent management updates

Recent updates

ImmuCell (NASDAQ:ICCC) Is Making Moderate Use Of Debt

Aug 10
ImmuCell (NASDAQ:ICCC) Is Making Moderate Use Of Debt

Insufficient Growth At ImmuCell Corporation (NASDAQ:ICCC) Hampers Share Price

May 27
Insufficient Growth At ImmuCell Corporation (NASDAQ:ICCC) Hampers Share Price

ImmuCell GAAP EPS of -$0.09, revenue of $3.86M

Aug 11

ImmuCell announces preliminary 2Q sales of $3.9M

Jul 07

Health Check: How Prudently Does ImmuCell (NASDAQ:ICCC) Use Debt?

Sep 15
Health Check: How Prudently Does ImmuCell (NASDAQ:ICCC) Use Debt?

Why We Think Shareholders May Be Considering Bumping Up ImmuCell Corporation's (NASDAQ:ICCC) CEO Compensation

Jun 10
Why We Think Shareholders May Be Considering Bumping Up ImmuCell Corporation's (NASDAQ:ICCC) CEO Compensation

Is ImmuCell (NASDAQ:ICCC) Using Too Much Debt?

Mar 15
Is ImmuCell (NASDAQ:ICCC) Using Too Much Debt?

Does ImmuCell's (NASDAQ:ICCC) Share Price Gain of 38% Match Its Business Performance?

Jan 22
Does ImmuCell's (NASDAQ:ICCC) Share Price Gain of 38% Match Its Business Performance?

ImmuCell reports FY20 preliminary sales

Jan 07

ImmuCell restructures its bank debt

Dec 15

ImmuCell EPS beats by $0.04, beats on revenue

Nov 12

CEO Compensation Analysis

How has Michael Brigham's remuneration changed compared to ImmuCell's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$395kUS$355k

-US$6m

Sep 30 2023n/an/a

-US$6m

Jun 30 2023n/an/a

-US$6m

Mar 31 2023n/an/a

-US$5m

Dec 31 2022US$600kUS$343k

-US$2m

Sep 30 2022n/an/a

-US$752k

Jun 30 2022n/an/a

US$51k

Mar 31 2022n/an/a

US$876k

Dec 31 2021US$360kUS$331k

-US$78k

Sep 30 2021n/an/a

US$36k

Jun 30 2021n/an/a

-US$434k

Mar 31 2021n/an/a

-US$1m

Dec 31 2020US$354kUS$325k

-US$1m

Sep 30 2020n/an/a

-US$2m

Jun 30 2020n/an/a

-US$2m

Mar 31 2020n/an/a

-US$2m

Dec 31 2019US$344kUS$315k

-US$1m

Sep 30 2019n/an/a

-US$2m

Jun 30 2019n/an/a

-US$2m

Mar 31 2019n/an/a

-US$2m

Dec 31 2018US$426kUS$309k

-US$2m

Sep 30 2018n/an/a

-US$1m

Jun 30 2018n/an/a

-US$2m

Mar 31 2018n/an/a

-US$974k

Dec 31 2017US$411kUS$299k

-US$168k

Compensation vs Market: Michael's total compensation ($USD395.24K) is below average for companies of similar size in the US market ($USD667.11K).

Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.

CEO

Michael Brigham (62 yo)

32.5yrs

Tenure

US$395,235

Compensation

Mr. Michael F. Brigham has been the Chief Executive Officer and President of Immucell Corporation since February 2000 and its Principal Financial Officer and Treasurer since October 1991. Mr. Brigham has b...

Leadership Team

NamePositionTenureCompensationOwnership
Michael Brigham
President32.5yrsUS$395.24k2.78%
$ 1.1m
Bobbi Brockmann
VP of Sales & Marketing and Director9.2yrsUS$323.52k0.11%
$ 42.9k
Elizabeth Toothaker
Director of Finance & Administration and Controllerno datano datano data
A. Scaffa
Senior Director of Quality5.7yrsno datano data
John Zinckgraf
Director of Product Developmentno datano datano data

9.2yrs

Average Tenure

Experienced Management: ICCC's management team is seasoned and experienced (9.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Michael Brigham
President25.1yrsUS$395.24k2.78%
$ 1.1m
Bobbi Brockmann
VP of Sales & Marketing and Director6.3yrsUS$323.52k0.11%
$ 42.9k
Paul Wainman
Independent Director10.1yrsUS$30.00k0.081%
$ 31.5k
David Tomsche
Independent Chairman of the Board17.3yrsUS$42.00k1.34%
$ 521.1k
Steven Rosgen
Independent Director6.3yrsUS$30.00k0%
$ 0
Gloria Basse
Independent Director3.8yrsUS$28.00kno data
Bryan Gathagan
Independent Directorless than a yearUS$50.70kno data

6.3yrs

Average Tenure

58yo

Average Age

Experienced Board: ICCC's board of directors are considered experienced (6.3 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.